A Yearlong Calendar for Stock Research and Company Reviews

Anchor the review year to each company’s reporting calendar

A twelve-month stock-research plan is a sequence for revisiting evidence, not a forecast of when a company will deliver good or bad news. Issuers have different fiscal year-ends and release schedules, so begin with the latest filing and investor-relations calendar for each holding or research candidate. Mark expected reporting windows as estimates until the company confirms them. Use the calendar alongside common income-statement errors to check how reported earnings affect the thesis.

At the start of the cycle, write a short thesis, the operating measures that matter, the valuation approach, and the evidence that would weaken the view. Save the source links and share-count date. That dated baseline makes later reviews a comparison with what was known, instead of a reconstruction shaped by the latest stock move.

Use quarterly results to refresh the business case

Around each earnings release, compare results with the prior period and the company’s own guidance. Revisit revenue drivers, margins, cash conversion, debt, and diluted shares; then record which changes came from operations and which from acquisitions, accounting, or one-off items. If the company reports by segment, keep the segment bridge so a consolidated headline does not hide different trajectories.

Do not force every check into an identical three-month rhythm. A company may issue an interim update, file a material event, or change guidance between regular reports. Add a review when a meaningful filing arrives, and keep a clear distinction between confirmed evidence and calendar reminders that have not yet produced new information.

• Before a report: capture the prior guidance and the open questions.
• After a report: reconcile reported figures with the thesis drivers.
• Between reports: record material filings or company-announced changes.

Schedule valuation and exposure reviews at different intervals

Refresh valuation when operating assumptions, financing needs, or share count materially change; a calendar date alone does not make an old multiple newly informative. At a planned valuation review or after a material change, confirm that peers still have similar business models, fiscal periods, and capital structures. Keep a separate record for dividends, issuance, repurchases, and other events that alter the per-share claim.

Review portfolio exposure on its own schedule. Concentration, sector overlap, liquidity, and event dates can change even when the long-run company thesis remains stable. This is a check on the portfolio context, not an instruction to trade; note the reason for any change and the evidence that prompted it.

Close the year by auditing the research process

At year-end, compare the original questions with the information that actually became available. Identify which assumptions held, which were wrong, and which could not be tested because the company did not disclose enough. Review how often the notes were updated, whether primary filings were saved, and whether a price target or market narrative displaced the operating evidence.

Carry unresolved questions into the next cycle rather than converting them into predictions. A calendar can make research more orderly while leaving the future uncertain; earnings, litigation, regulation, and market conditions do not follow a personal review schedule. This is educational information, not individualized investment, tax, legal, or accounting advice.